Anti-Cancer Drugs
Lippincott Williams and Wilkins · United States
Aims & Scope✦ Inferred from recent articles
This journal focuses on the development and evaluation of anti-cancer drugs and therapies. Research includes the synthesis of novel prodrugs, drug repurposing, and the investigation of drug mechanisms of action in various cancer types such as hepatocellular carcinoma, oesophageal squamous cell carcinoma, leiomyosarcoma, endometrial cancer, lung cancer, bladder cancer, breast cancer, gastric cancer, thymic carcinoma, salivary duct carcinoma, and neuroblastoma. Studies also explore combination therapies, including chemotherapy with immunotherapy or targeted agents, and the management of drug resistance and adverse effects.
AI-summarised from recent articles · verify on publisher page →
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Subject Classification
Web of Science Categories
Scopus Categories
Research Topics (OpenAlex)
You May Also Like
See all →Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref